Denmark· DK-28105538814
Ongentys
A opicapone product containing opicapon, registered in Denmark by Bial Portela & Ca S.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Opicapone is registered in 14 of 19 countries.
Countries holding a registration under ATC N04BX04 (opicapone), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Opicapone · ATC N04BX04
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of opicapone costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Opicapone · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.01
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- opicapon
- Manufacturer
- Bial Portela & Ca S.A.
- Country
- Denmark (DK)
- ATC code
- N04BX04
- ATC class
- Opicapone
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105538814
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
69 interactions on record for opicapone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Opicapone · interactions on record
69 records
- 2 severe
- 67 moderate
Most severe, free to view
- ProcarbazineL01XB01severe
- Methylthioninium chlorideV03AB17severe
- EpinephrineA01AD01moderate
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N04BX04
Opicapone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f95f2222-a236-4ecf-8cd9-6bc5b1d675e8 GET /v1/drugs/f95f2222-a236-4ecf-8cd9-6bc5b1d675e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, hårde",
"source": "dkma",
"strength": "50 mg",
"auth_role": "CO-RAP",
"dk_drugid": "28105538814",
"substance": "opicapon",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42545"
}See everything about opicapone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.